"We believe helping people understand their infection status has shown to be one of the most effective methods for controlling the spread of COVID-19. Enabling patients and providers to know this information at the point-of-care in 20 minutes can help further reduce the risk of virus transmission and improve patient outcomes. We are very proud to offer this test in Brazil and assist in efforts to manage the global pandemic." Chembio Diagnostics Brazil, formerly Orangelife Comercio e Industria Ltda., is Chembio's Brazilian commercial subsidiary that Chembio acquired in November 2019.